COMMUNIQUÉS West-GlobeNewswire

Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
EVANSTON, Ill., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Albireo to Present at Wedbush PacGrow Healthcare Conference
06/08/2019
BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
Yield10 Bioscience to Announce Second Quarter 2019 Financial Results and Host a Conference Call on Monday, August 12, 2019
06/08/2019
WOBURN, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Bhang Brings Hemp-derived CBD Product Portfolio to Spain, France, Italy, Belgium, Luxembourg & the U.K.
06/08/2019
Global cannabis house of brands now has distribution in seven countries across two continents. MIAMI, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Bhang Inc. (“Bhang” or the “Company”) (CSE: BHNG) , a global cannabis house of [...]
Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results
06/08/2019
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
06/08/2019
This press release is not for dissemination in the United States or through US newswire services CALGARY, Alberta, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith”) announced today that Zenith [...]
Teladoc Health to Participate in Upcoming Investor Conferences
06/08/2019
PURCHASE, NY, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief financial [...]
CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA® (iobenguane I 131)
06/08/2019
Provides Additional Medicare Reimbursement up to 65% of the Cost of AZEDRA Prescribed for Inpatient Medicare Patients NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an [...]
Forty Seven, Inc. Announces $6 Million in Funding from the Leukemia & Lymphoma Society TAP to Accelerate the Development of 5F9 in Myelodysplastic Syndrome
06/08/2019
MENLO PARK, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc., a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced [...]
Allena Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
NEWTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
DNARx Awarded DARPA Contract for up to $10.7 Million to Develop Non-Viral DNA-Encoded Gene Therapy to Protect Against Pandemic Influenza
06/08/2019
DNARx’s proprietary HEDGES™ non-viral gene therapy delivery platform promises rapid, reliable, low-cost and relatively simple manufacturing and delivery of gene vectors to treat a wide range of diseases, particularly as [...]
electroCore to Announce Second Quarter 2019 Financial Results on Tuesday, August 13
06/08/2019
Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report [...]
In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1
06/08/2019
Updated Cancer Risk Estimates Will Allow For More Personalized Risk Assessment and Informed Decision Making For Patients with Rare Form of Hereditary Stomach Cancer GAITHERSBURG, Md., Aug. 06, 2019 (GLOBE NEWSWIRE) -- [...]
Entasis Therapeutics to Present at the Wedbush PacGrow Healthcare Conference
06/08/2019
WALTHAM, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Mersana Therapeutics to Present at the Wedbush PacGrow Healthcare Conference
06/08/2019
CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Zynerba Pharmaceuticals Announces Publication of Zygel™ (ZYN002) 12-week Open Label Fragile X Syndrome Data in the Journal of Neurodevelopmental Disorders
06/08/2019
DEVON, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference
06/08/2019
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Passage Bio to Present at 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
PHILADELPHIA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced that [...]
Leading Immunobiology Researcher Dr. David Briscoe Joins aTyr Pharma as Scientific Advisor
06/08/2019
Dr. Briscoe to advise company on ongoing development of therapeutics based on the Neuropilin-2 (NRP2) co-receptor and related signaling pathways SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: [...]

Pages